Dopamine-dependent neurotoxicity of α-synuclein:: A mechanism for selective neurodegeneration in Parkinson disease

被引:632
作者
Xu, J
Kao, SY
Lee, FJS
Song, WH
Jin, LW
Yankner, BA [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[2] Childrens Hosp, Div Neurosci, Boston, MA 02115 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
关键词
D O I
10.1038/nm0602-600
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism by which dopaminergic neurons are selectively lost in Parkinson disease (PD) is unknown. Here we show that accumulation of alpha-synuclein in cultured human dopaminergic neurons results in apoptosis that requires endogenous dopamine production and is mediated by reactive oxygen species. In contrast, alpha-synuclein is not toxic in non-dopaminergic human cortical neurons, but rather exhibits neuroprotective activity. Dopamine-dependent neurotoxicity is mediated by 54-83-kD soluble protein complexes that contain alpha-synuclein and 14-3-3 protein, which are elevated selectively in the substantia nigra in PD. Thus, accumulation of soluble alpha-synuclein protein complexes can render endogenous dopamine toxic, suggesting a potential mechanism for the selectivity of neuronal loss in PD.
引用
收藏
页码:600 / 606
页数:7
相关论文
共 30 条
[1]  
Baba M, 1998, AM J PATHOL, V152, P879
[2]  
BREAKEFIELD XO, P NATL ACAD SCI US, V71, P2530
[3]   APOPTOSIS AND INCREASED GENERATION OF REACTIVE OXYGEN SPECIES IN DOWNS-SYNDROME NEURONS IN-VITRO [J].
BUSCIGLIO, J ;
YANKNER, BA .
NATURE, 1995, 378 (6559) :776-779
[4]   The solubility of α-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease [J].
Campbell, BCV ;
McLean, CA ;
Culvenor, JG ;
Gai, WP ;
Blumbergs, PC ;
Jäkälä, P ;
Beyreuther, K ;
Masters, CL ;
Li, QX .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) :87-96
[5]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[6]   Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct [J].
Conway, KA ;
Rochet, JC ;
Bieganski, RM ;
Lansbury, PT .
SCIENCE, 2001, 294 (5545) :1346-1349
[7]   Wild-type but not Parkinson's disease-related Ala-53 → Thr mutant α-synuclein protects neuronal cells from apoptotic stimuli [J].
da Costa, CA ;
Ancolio, K ;
Checler, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :24065-24069
[8]  
Drukarch B, 1996, J NEUROSCI, V16, P6038
[9]   A Drosophila model of Parkinson's disease [J].
Feany, MB ;
Bender, WW .
NATURE, 2000, 404 (6776) :394-398
[10]   Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions [J].
Giasson, BI ;
Duda, JE ;
Murray, IVJ ;
Chen, QP ;
Souza, JM ;
Hurtig, HI ;
Ischiropoulos, H ;
Trojanowski, JQ ;
Lee, VMY .
SCIENCE, 2000, 290 (5493) :985-989